⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Lekli Pharma (LEKLI sh.p.k.) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Lekli Pharma (LEKLI sh.p.k.)
↗Tirana, Albania
Lekli Pharma is a family-owned pharmaceutical company based in Tirana, Albania, with over 25 years of experience in the Balkan market. The company specializes in market research and the manufacturing of medical products, including generic drugs, phytotherapeutics, and orphan drugs for rare diseases, with a strong focus on addressing unmet medical needs in Albania and the surrounding region.
In 2015, the company established its own production facility to manufacture pharmaceutical preparations. Recently, the company inaugurated a new high-tech manufacturing facility, 'LEKLI SCIENCES,' in the Tirana Industrial Park, which was visited by the Prime Minister of Albania in April 2025, highlighting its role in the development of the national pharmaceutical industry.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Generics and Rare Disease Therapeutics
SIZE & FINANCIALS
Employees:1-50
Revenue:$5M
Founded:1991
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Biotest (Distribution/Network partner)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Luan Lekli - Founder/Dr.
Kristian Lekli - Management Team
David Lekli - Management Team
Scientific Founders:Dr. Luan Lekli
LINKS
Website:leklipharma.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Lekli Pharma (LEKLI sh.p.k.). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.